Celbira Tablet

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Celbira Tablet contains abiraterone acetate, an androgen biosynthesis (CYP17) inhibitor. Its labelling describes it for the treatment of prostate gland cancer, and it may also be prescribed for other conditions. It is described as preventing the production of testosterone in males, which slows the growth of cancer cells and relieves symptoms such as difficulty in urination. The doctor decides whether it is taken with food or on an empty stomach.

Active ingredient
Abiraterone acetate
Dosage form
Oral tablet
Therapeutic class
Androgen biosynthesis inhibitor (CYP17 inhibitor)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of prostate gland cancer
  • Described as also prescribed for other conditions as the doctor sees fit
  • Described as preventing testosterone production in males, slowing the growth of cancer cells and relieving symptoms such as difficulty in urination
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Taken in the dose, interval, and duration prescribed by the doctor
  • Swallowed whole; the tablet should not be chewed, broken, or crushed
  • Can be taken on an empty stomach, or with food if the doctor advises

Described Side Effects

Commonly described side effects include:

  • Swelling
  • Vomiting
  • Decreased potassium level in the blood
  • Fatigue
  • Anaemia
  • Diarrhoea
  • High blood pressure
  • Cough

These are described as commonly temporary. The doctor should be consulted if they are bothersome.

Precautions

  • The doctor should be informed of heart issues, liver or kidney issues, high blood pressure, and any other medicines being taken
  • Effective contraception should be used to avoid pregnancy
  • Regular monitoring of blood glucose level may be carried out and should be cooperated with

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains abiraterone acetate and is used for the treatment of prostate gland cancer. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as swallowed whole in the dose, interval, and duration prescribed by the doctor, without chewing, breaking, or crushing; the doctor decides whether it is taken with food or on an empty stomach.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services